Rajeev Saggar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rajeev Saggar Sells 1,649 Shares of Liquidia Co (NASDAQ:LQDA) Stock

Rajeev Saggar Sells 1,649 Shares of Liquidia Co (NASDAQ:LQDA) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLiquidia coLb partnersSecurities exchange commissionLiquidia corporationLiquidia company profileVanguard group incNeedham companyFortitude family officeGet free reportRajeev saggarExchange commissionFamily officeAigen investment managementLiquidia daily

Rajeev Saggar Sells 1,649 Shares of Liquidia Co (NASDAQ:LQDA) Stock

Rajeev Saggar Sells 1,649 Shares of Liquidia Co (NASDAQ:LQDA) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesSg americas securitiesNeedham companyFortitude family officeTower research capitalLiquidia corporationSimplicity solutionsLiquidia coGet free reportRajeev saggarFamily officeInvestment managementResearch capitalLiquidia daily

Liquidia Technologies (LQDA) Announces FDA Acceptance of Submission to Add PH-ILD to YUTREPIA Label

Liquidia Technologies (LQDA) Announces FDA Acceptance of Submission to Add PH-ILD to YUTREPIA Label
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUs district courtYork heart associationLiquidia corporationLiquidia corporation the companyDrug administrationLiquidia technologies incUnited therapeutics corporationPrescription drug user fee actRajeev saggarChief medical officerUnited therapeuticsNew york heart associationFunctional classDry powder inhalationLiquidia technologies

FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label

Sets PDUFA goal date of January 24, 2024If approved, YUTREPIA would be indicated for treatment of both PAH and PH-ILD MORRISVILLE, N.C., Sept. 25, 2023 Liquidia Corporation announced today.

United statesJason adairUs district courtYork heart associationLiquidia corporation the companyLiquidia corporationLiquidia technologies incUnited therapeutics corporationDrug administrationPrescription drug user fee actRajeev saggarChief medical officerUnited therapeuticsNew york heart associationFunctional classDry powder inhalation

FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label

FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
itnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnewsonline.com Daily Mail and Mail on Sunday newspapers.

United statesJason adairYork heart associationUs district courtLiquidia technologies incDrug administrationLiquidia corporation the companyLiquidia corporationUnited therapeutics corporationPrescription drug user fee actRajeev saggarChief medical officerUnited therapeuticsNew york heart associationFunctional classDry powder inhalation